Neurotransmitters and neuropeptides in depression.

[1]  Murat Yücel,et al.  Volumetric MRI study of the insular cortex in individuals with current and past major depression. , 2010, Journal of affective disorders.

[2]  E. Eşel,et al.  Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment , 2009, Psychiatry Research.

[3]  J. Korf,et al.  The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  N. Wray,et al.  Accurate, Large-Scale Genotyping of 5HTTLPR and Flanking Single Nucleotide Polymorphisms in an Association Study of Depression, Anxiety, and Personality Measures , 2009, Biological Psychiatry.

[5]  J. Deakin,et al.  Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. , 2009, Journal of psychiatric research.

[6]  M. Yücel,et al.  Midline brain structures in patients with current and remitted major depression , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  B. Bogerts,et al.  Evidence for structural abnormalities of the human habenular complex in affective disorders but not in schizophrenia , 2009, Psychological Medicine.

[8]  D. Swaab,et al.  Hypothalamic Vasopressin and Oxytocin mRNA Expression in Relation to Depressive State in Alzheimer’s Disease: A Difference With Major Depressive Disorder , 2009, Journal of neuroendocrinology.

[9]  Yanhua Lin,et al.  Sex differences in stress responses: Focus on ovarian hormones , 2009, Physiology & Behavior.

[10]  Dennis S. Charney,et al.  Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder , 2009, Biological Psychiatry.

[11]  Peter Boesiger,et al.  The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. , 2009, Archives of general psychiatry.

[12]  M. Yücel,et al.  Anterior cingulate cortex abnormalities associated with a first psychotic episode in bipolar disorder , 2009, British Journal of Psychiatry.

[13]  M. Weissman,et al.  Cortical thinning in persons at increased familial risk for major depression , 2009, Proceedings of the National Academy of Sciences.

[14]  Tianzi Jiang,et al.  Decreased gyrification in major depressive disorder , 2009, Neuroreport.

[15]  A M McIntosh,et al.  Prefrontal gyral folding and its cognitive correlates in bipolar disorder and schizophrenia , 2009, Acta psychiatrica Scandinavica.

[16]  M. Ikeda,et al.  Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[17]  B. Bogerts,et al.  Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil. , 2009, Journal of affective disorders.

[18]  L. Träskman-bendz,et al.  Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. , 2009, Journal of affective disorders.

[19]  M. Ekker,et al.  Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior , 2008, Molecular Psychiatry.

[20]  M. Ekker,et al.  Conditional CRH overexpressing mice: an animal model for stress-elicited pathologies and treatments that target the central CRH system , 2008, Molecular Psychiatry.

[21]  C. Bouras,et al.  Assessing the role of cingulate cortex in bipolar disorder: Neuropathological, structural and functional imaging data , 2008, Brain Research Reviews.

[22]  Jacqueline K. Wittke-Thompson,et al.  Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[23]  Nancy L Pedersen,et al.  Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans , 2008, Proceedings of the National Academy of Sciences.

[24]  P. Cowen.  Serotonin and depression: pathophysiological mechanism or marketing myth? , 2008, Trends in pharmacological sciences.

[25]  Steven C. R. Williams,et al.  Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. , 2008, Archives of general psychiatry.

[26]  M. Furey,et al.  Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression , 2008, Brain Structure and Function.

[27]  R. Belmaker.  The Future of Depression Psychopharmacology , 2008, CNS Spectrums.

[28]  D. Swaab,et al.  Depression laser-dissected , 2008, Molecular Psychiatry.

[29]  P. Jezzard,et al.  Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy , 2008, Journal of psychopharmacology.

[30]  Dick F Swaab,et al.  Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. , 2008, JAMA.

[31]  D F Swaab,et al.  Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances , 2008, Molecular Psychiatry.

[32]  C. Belzung,et al.  Involvement of vasopressin in affective disorders. , 2008, European journal of pharmacology.

[33]  E. Frank,et al.  The vasopressin system--from antidiuresis to psychopathology. , 2008, European journal of pharmacology.

[34]  D. F. Swaab,et al.  The stress system in depression and neurodegeneration: Focus on the human hypothalamus , 2008, Brain Research Reviews.

[35]  Marzena Wylezinska,et al.  Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. , 2008, The international journal of neuropsychopharmacology.

[36]  A. Kalsbeek,et al.  Opposite actions of hypothalamic vasopressin on circadian corticosterone rhythm in nocturnal versus diurnal species , 2008, The European journal of neuroscience.

[37]  B. Scheithauer,et al.  Immunoexpression of Androgen Receptor in the Nontumorous Pituitary and in Adenomas , 2008, Endocrine pathology.

[38]  V. Arango,et al.  Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides , 2008, Molecular Psychiatry.

[39]  R. Belmaker,et al.  Major depressive disorder. , 2008, The New England journal of medicine.

[40]  D. Rujescu,et al.  Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: Focus on vasopressin and glyoxalase-I , 2007, Neuroscience & Biobehavioral Reviews.

[41]  Mark A Frye,et al.  Increased Anterior Cingulate/Medial Prefrontal Cortical Glutamate and Creatine in Bipolar Depression , 2007, Neuropsychopharmacology.

[42]  B. Leonard.  Psychopathology of depression. , 2007, Drugs of today.

[43]  J. Gádoros,et al.  Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders. , 2007, Archives of general psychiatry.

[44]  John Suckling,et al.  Brain Imaging Correlates of Depressive Symptom Severity and Predictors of Symptom Improvement After Antidepressant Treatment , 2007, Biological Psychiatry.

[45]  J. Meador-Woodruff,et al.  Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders , 2007, Neuropsychopharmacology.

[46]  L. Träskman-bendz,et al.  Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder , 2007, European Neuropsychopharmacology.

[47]  Z. Mei,et al.  Reduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1 , 2007, Neuropsychopharmacology.

[48]  G. Sanacora,et al.  GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. , 2007, CNS & neurological disorders drug targets.

[49]  P. Matthews,et al.  Reduction in Occipital Cortex γ-Aminobutyric Acid Concentrations in Medication-Free Recovered Unipolar Depressed and Bipolar Subjects , 2007, Biological Psychiatry.

[50]  D. Swaab,et al.  Relation between Corticotropin-Releasing Hormone Neuron Number in the Hypothalamic Paraventricular Nucleus and Depressive State in Alzheimer’s Disease , 2007, Neuroendocrinology.

[51]  D. Jezova,et al.  Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats , 2007, Hormones and Behavior.

[52]  D. Swaab,et al.  Gender Difference in Age-Related Number of Corticotropin-Releasing Hormone-Expressing Neurons in the Human Hypothalamic Paraventricular Nucleus and the Role of Sex Hormones , 2007, Neuroendocrinology.

[53]  D. Swaab,et al.  Hypothalamic oxytocin mRNA expression and melancholic depression , 2007, Molecular Psychiatry.

[54]  W. Young,et al.  The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. , 2007, Endocrinology.

[55]  Gregor Hasler,et al.  Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. , 2007, Archives of general psychiatry.

[56]  A. Schene,et al.  Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies , 2007, Molecular Psychiatry.

[57]  L. Christiansen,et al.  Candidate Gene Polymorphisms in the Serotonergic Pathway: Influence on Depression Symptomatology in an Elderly Population , 2007, Biological Psychiatry.

[58]  B. Dean,et al.  Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder , 2007, Brain Research.

[59]  B. Bogerts,et al.  Dysregulation of GABAergic Neurotransmission in Mood Disorders , 2007, Annals of the New York Academy of Sciences.

[60]  C. Stockmeier,et al.  Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicide , 2006, Brain Research.

[61]  D. Swaab,et al.  Increased Arginine Vasopressin mRNA Expression in the Human Hypothalamus in Depression: A Preliminary Report , 2006, Biological Psychiatry.

[62]  F. Ohl,et al.  Differential disinhibition of the neonatal hypothalamic– pituitary–adrenal axis in brain‐specific CRH receptor 1‐knockout mice , 2006, The European journal of neuroscience.

[63]  W. Drevets,et al.  Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. , 2006, Archives of general psychiatry.

[64]  J. Deakin,et al.  Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder , 2006, Neuroscience Letters.

[65]  Z. Cao,et al.  Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression , 2006, Neuroscience Letters.

[66]  A. Kalsbeek,et al.  Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the “master clock” , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  P. McGuire,et al.  Neuroimaging and electrophysiological studies of the effects of acute tryptophan depletion: a systematic review of the literature , 2006, Psychopharmacology.

[68]  Jelle Jolles,et al.  Acute tryptophan depletion improves performance and modulates the BOLD response during a Stroop task in healthy females , 2006, NeuroImage.

[69]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[70]  Philip K. McGuire,et al.  Effect of acute tryptophan depletion on pre-frontal engagement , 2006, Psychopharmacology.

[71]  E. Hol,et al.  A direct androgenic involvement in the expression of human corticotropin-releasing hormone , 2006, Molecular Psychiatry.

[72]  J. Jolles,et al.  The effect of acute tryptophan depletion on the BOLD response during performance monitoring and response inhibition in healthy male volunteers , 2006, Psychopharmacology.

[73]  S. Orr,et al.  Sex-specific influences of vasopressin on human social communication , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[74]  C. Marsden,et al.  Differential Effects of Acute and Chronic Social Defeat Stress on Hypothalamic‐Pituitary‐Adrenal Axis Function and Hippocampal Serotonin Release in Mice , 2006, Journal of neuroendocrinology.

[75]  D. Swaab,et al.  Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression , 2006, Neurobiology of Aging.

[76]  R. Ebstein,et al.  Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills , 2006, Molecular Psychiatry.

[77]  P. Delgado.  Monoamine depletion studies: implications for antidepressant discontinuation syndrome. , 2006, The Journal of clinical psychiatry.

[78]  H. Anisman,et al.  Corticotropin-Releasing Hormone, Arginine Vasopressin, Gastrin-Releasing Peptide, and Neuromedin B Alterations in Stress-Relevant Brain Regions of Suicides and Control Subjects , 2006, Biological Psychiatry.

[79]  D. Swaab,et al.  Glucocorticoids suppress vasopressin gene expression in human suprachiasmatic nucleus , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[80]  K. Zwinderman,et al.  Depression with above-normal plasma vasopressin: Validation by relations with family history of depression and mixed anxiety and retardation , 2006, Psychiatry Research.

[81]  Michael A Rapp,et al.  Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. , 2006, Archives of general psychiatry.

[82]  L. Price,et al.  Open-label tiagabine monotherapy for major depressive disorder with anxiety. , 2006, The Journal of clinical psychiatry.

[83]  Peter S Talbot,et al.  Anterior Cingulate and Subgenual Prefrontal Blood Flow Changes Following Tryptophan Depletion in Healthy Males , 2006, Neuropsychopharmacology.

[84]  J. Deakin,et al.  NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder , 2005, Schizophrenia Research.

[85]  Sylvain Houle,et al.  Effects of Tryptophan Depletion on the Serotonin Transporter in Healthy Humans , 2005, Biological Psychiatry.

[86]  P. Renshaw,et al.  Reduced Anterior Cingulate Glutamate in Pediatric Major Depression: A Magnetic Resonance Spectroscopy Study , 2005, Biological Psychiatry.

[87]  R. Myers,et al.  Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[88]  C. Stockmeier,et al.  Elevated Levels of the NR2C Subunit of the NMDA Receptor in the Locus Coeruleus in Depression , 2005, Neuropsychopharmacology.

[89]  D. Nutt,et al.  Acute Tryptophan Depletion. Part I: Rationale and Methodology , 2005, The Australian and New Zealand journal of psychiatry.

[90]  A. James,et al.  5-Hydroxytryptamine 1A Receptors in the Paraventricular Nucleus of the Hypothalamus Mediate Oxytocin and Adrenocorticotropin Hormone Release and Some Behavioral Components of the Serotonin Syndrome , 2005, Journal of Pharmacology and Experimental Therapeutics.

[91]  Andon Hestiantoro,et al.  Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. , 2005, Brain : a journal of neurology.

[92]  B. McEwen.  Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. , 2005, Metabolism: clinical and experimental.

[93]  D. Swaab,et al.  The stress system in the human brain in depression and neurodegeneration , 2005, Ageing Research Reviews.

[94]  James Robert Brašić,et al.  Relationships Among Ventral Striatal Dopamine Release, Cortisol Secretion, and Subjective Responses to Amphetamine , 2005, Neuropsychopharmacology.

[95]  R. Landgraf,et al.  Regulation of activity‐dependent dendritic vasopressin release from rat supraoptic neurones , 2005, The Journal of physiology.

[96]  T. Robbins,et al.  Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces , 2005, Psychopharmacology.

[97]  Anna Wirz-Justice,et al.  Chronotherapeutics (light and wake therapy) in affective disorders , 2005, Psychological Medicine.

[98]  Alan L. Miller,et al.  Epidemiology, etiology, and natural treatment of seasonal affective disorder. , 2005, Alternative medicine review : a journal of clinical therapeutic.

[99]  H. Akil.  Stressed and depressed , 2005, Nature Medicine.

[100]  Cynthia H. Y. Fu,et al.  Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI , 2005, Psychopharmacology.

[101]  S. Fatemi,et al.  GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum , 2005, Schizophrenia Research.

[102]  R. Kahn,et al.  Hippocampal changes and white matter lesions in early-onset depression , 2004, Biological Psychiatry.

[103]  Alan A. Wilson,et al.  Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor–treated depression: An [18F] MPPF positron emission tomography study , 2004, Biological Psychiatry.

[104]  M. Joëls,et al.  Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus , 2004, The European journal of neuroscience.

[105]  C. Wotjak,et al.  The hypothalamic–neurohypophysial system regulates the hypothalamic–pituitary–adrenal axis under stress: An old concept revisited , 2004, Frontiers in Neuroendocrinology.

[106]  B. Pollock,et al.  Meta-analysis of serotonin transporter polymorphisms and affective disorders , 2004, Psychiatric genetics.

[107]  Peter Herscovitch,et al.  Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. , 2004, Archives of general psychiatry.

[108]  John H Krystal,et al.  Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. , 2004, Archives of general psychiatry.

[109]  T. Woo,et al.  Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. , 2004, Archives of general psychiatry.

[110]  T. Gray,et al.  Desensitization of 5-HT1A Receptors by 5-HT2A Receptors in Neuroendocrine Neurons in Vivo , 2004, Journal of Pharmacology and Experimental Therapeutics.

[111]  Alan J. Thomas,et al.  Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression. , 2004, The American journal of psychiatry.

[112]  J. Herman,et al.  Role of GABA and Glutamate Circuitry in Hypothalamo‐Pituitary‐Adrenocortical Stress Integration , 2004, Annals of the New York Academy of Sciences.

[113]  M. Webster,et al.  Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium , 2004, Molecular Psychiatry.

[114]  K. Kovács,et al.  GABAergic Mechanisms Constraining the Activity of the Hypothalamo‐Pituitary‐Adrenocortical Axis , 2004, Annals of the New York Academy of Sciences.

[115]  Jens C. Pruessner,et al.  Dopamine Release in Response to a Psychological Stress in Humans and Its Relationship to Early Life Maternal Care: A Positron Emission Tomography Study Using [11C]Raclopride , 2004, The Journal of Neuroscience.

[116]  J. Price,et al.  Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes , 2004, Biological Psychiatry.

[117]  M. C. Oliveira,et al.  Immunohistochemical Detection of Estrogen Receptor Alpha in Pituitary Adenomas and Its Correlation with Cellular Replication , 2004, Neuroendocrinology.

[118]  David R Rosenberg,et al.  Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[119]  R. Handa,et al.  Androgen Inhibits, While Oestrogen Enhances, Restraint‐Induced Activation of Neuropeptide Neurones in the Paraventricular Nucleus of the Hypothalamus , 2004, Journal of neuroendocrinology.

[120]  H. Anisman,et al.  Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region , 2004, The Journal of Neuroscience.

[121]  D. Muller,et al.  Local γ‐aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin‐releasing factor neuron activity in the paraventricular nucleus of the hypothalamus , 2004 .

[122]  E. Someren,et al.  Diurnal rhythms of free estradiol and cortisol during the normal menstrual cycle in women with major depression , 2004, Hormones and Behavior.

[123]  T. Dinan,et al.  Further neuroendocrine evidence of enhanced vasopressin V3 receptor responses in melancholic depression , 2004, Psychological Medicine.

[124]  W. Riedel,et al.  Monoamine depletion in psychiatric and healthy populations: review , 2003, Molecular Psychiatry.

[125]  C. Duijn,et al.  A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression , 2003, Molecular Psychiatry.

[126]  A. Mackinnon,et al.  Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. , 2003, Bipolar disorders.

[127]  C. Benkelfat,et al.  A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior , 2003, Molecular Psychiatry.

[128]  R. Salomon,et al.  Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects , 2003, Biological Psychiatry.

[129]  C. Benkelfat,et al.  A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders , 2003, Molecular Psychiatry.

[130]  Eric Vermetten,et al.  Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. , 2003, JAMA.

[131]  Walter Heindel,et al.  Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham‐controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain , 2003, The European journal of neuroscience.

[132]  J. Gorman.  New molecular targets for antianxiety interventions. , 2003, The Journal of clinical psychiatry.

[133]  E. Florek,et al.  Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims. , 2003, Polish journal of pharmacology.

[134]  V. Arolt,et al.  Neurotrophic Effects of Electroconvulsive Therapy: A Proton Magnetic Resonance Study of the Left Amygdalar Region in Patients with Treatment-Resistant Depression , 2003, Neuropsychopharmacology.

[135]  S. Maier,et al.  Freewheel Running Prevents Learned Helplessness/Behavioral Depression: Role of Dorsal Raphe Serotonergic Neurons , 2003, The Journal of Neuroscience.

[136]  Martin Fiebich,et al.  Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients , 2003, Psychiatry Research: Neuroimaging.

[137]  T. Paunio,et al.  Circadian Clock-Related Polymorphisms in Seasonal Affective Disorder and their Relevance to Diurnal Preference , 2003, Neuropsychopharmacology.

[138]  J. Krystal,et al.  Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder , 2003, Psychopharmacology.

[139]  Abraham Weizman,et al.  Amantadine as augmentation therapy in the management of treatment-resistant depression , 2003, International clinical psychopharmacology.

[140]  W. Riedel,et al.  Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression , 2002, Psychiatry Research.

[141]  O. Petroff,et al.  Book Review: GABA and Glutamate in the Human Brain , 2002 .

[142]  P. Allard,et al.  [(3)H]Tiagabine binding to GABA transporter-1 (GAT-1) in suicidal depression. , 2002, Journal of affective disorders.

[143]  J. Price,et al.  Low glial numbers in the amygdala in major depressive disorder , 2002, Biological Psychiatry.

[144]  A. Kudoh,et al.  Small-Dose Ketamine Improves the Postoperative State of Depressed Patients , 2002, Anesthesia and analgesia.

[145]  S. Kasper,et al.  Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. , 2002, Archives of general psychiatry.

[146]  Paul J. Harrison,et al.  The neuropathology of primary mood disorder. , 2002, Brain : a journal of neurology.

[147]  F. Benes,et al.  Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. , 2002, Archives of general psychiatry.

[148]  J. Meador-Woodruff,et al.  Striatal Excitatory Amino Acid Transporter Transcript Expression in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder , 2002, Neuropsychopharmacology.

[149]  B. Bogerts,et al.  Circumscribed numerical deficit of dorsal raphe neurons in mood disorders , 2002, Psychological Medicine.

[150]  D. Swaab,et al.  Glucocorticoid treatment is associated with decreased expression of processed AVP but not of proAVP, neurophysin or oxytocin in the human hypothalamus: are PC1 and PC2 involved? , 2002, Neuro endocrinology letters.

[151]  M. Herman,et al.  Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression , 2002, Acta Neuropathologica.

[152]  F. Holsboer,et al.  Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus , 2001, The European journal of neuroscience.

[153]  J. Legros.  Inhibitory effect of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying–yang neurohormones? , 2001, Psychoneuroendocrinology.

[154]  J. Deakin,et al.  Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses , 2001, Neuroreport.

[155]  F. Benes,et al.  The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects , 2001, Biological Psychiatry.

[156]  N. Kalin,et al.  Corticotropin-releasing hormone messenger RNA distribution and stress-induced activation in the thalamus , 2001, Neuroscience.

[157]  D. Swaab,et al.  Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. , 2001, Archives of general psychiatry.

[158]  P F Liddle,et al.  Effects of rapid tryptophan depletion on brain 5-HT2 receptors: a PET study , 2001, British Journal of Psychiatry.

[159]  L. Selemon,et al.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder , 2001, Biological Psychiatry.

[160]  A. V. D. Does,et al.  The effects of tryptophan depletion on mood and psychiatric symptoms. , 2001 .

[161]  C. Bell,et al.  Tryptophan depletion and its implications for psychiatry , 2001, British Journal of Psychiatry.

[162]  G. Gimpl,et al.  The oxytocin receptor system: structure, function, and regulation. , 2001, Physiological reviews.

[163]  G. Kerkhof,et al.  Weak 24-h periodicity of body temperature and increased plasma vasopressin in melancholic depression , 2001, European Neuropsychopharmacology.

[164]  F. Holsboer,et al.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. , 2001, The American journal of pathology.

[165]  Alan J. Thomas,et al.  Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology , 2001, Biological Psychiatry.

[166]  A. Chocyk,et al.  Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: an immunohistochemical study. , 2000, Brain research. Molecular brain research.

[167]  Mark E. Williams,et al.  Glutamate decarboxylase65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain , 2000, Journal of Chemical Neuroanatomy.

[168]  Camellia P. Clark,et al.  Clinical and Physiological Consequences of Rapid Tryptophan Depletion , 2000, Neuropsychopharmacology.

[169]  G. MacQueen,et al.  Increased hippocampal supragranular Timm staining in subjects with bipolar disorder , 2000, Neuroreport.

[170]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[171]  J. Kleinman,et al.  Neuropathology of bipolar disorder , 2000, Biological Psychiatry.

[172]  M. Keck,et al.  Vasopressin, major depression, and hypothalamic–pituitary–adrenocortical desensitization , 2000, Biological Psychiatry.

[173]  Paul J. Harrison,et al.  Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs , 2000, Molecular Psychiatry.

[174]  M. Castillo,et al.  Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. , 2000, AJNR. American journal of neuroradiology.

[175]  H. Anisman,et al.  Dysthymia: a review of pharmacological and behavioral factors , 2000, Molecular Psychiatry.

[176]  W. Kamphorst,et al.  Decreased Vasopressin Gene Expression in the Biological Clock of Alzheimer Disease Patients With and Without Depression , 2000, Journal of neuropathology and experimental neurology.

[177]  R. Hirschfeld.  History and evolution of the monoamine hypothesis of depression. , 2000, The Journal of clinical psychiatry.

[178]  Bernadette Lipinski,et al.  Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study , 2000, Biological Psychiatry.

[179]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[180]  Fahmeed Hyder,et al.  Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy , 1999 .

[181]  V. Arango,et al.  Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims , 1999, Biological Psychiatry.

[182]  C. Berridge,et al.  Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[183]  S. Watson,et al.  Differential Regulation of Corticotropin-Releasing Hormone and Vasopressin Gene Transcription in the Hypothalamus by Norepinephrine , 1999, The Journal of Neuroscience.

[184]  Karl J. Friston,et al.  Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion , 1999, British Journal of Psychiatry.

[185]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[186]  S. Maier,et al.  Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor , 1999, Brain Research.

[187]  Jau-Shyong Hong,et al.  Heightened transcription for enzymes involved in norepinephrine biosynthesis in the rat locus coeruleus by immobilization stress , 1999, Biological Psychiatry.

[188]  Salehi,et al.  Activity of Vasopressinergic Neurones of the Human Supraoptic Nucleus os Age‐ and Sex‐Dependent , 1999, Journal of neuroendocrinology.

[189]  F. Rougé-Pont,et al.  Individual differences in stress‐induced dopamine release in the nucleus accumbens are influenced by corticosterone , 1998, The European journal of neuroscience.

[190]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[191]  M. Fava,et al.  Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial , 1998, Biological Psychiatry.

[192]  G. Aguilera,et al.  Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C. , 1998, Endocrinology.

[193]  P. Clark.  Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis , 1998, European Journal of Pediatrics.

[194]  D. Swaab,et al.  Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. , 1998, The Journal of clinical endocrinology and metabolism.

[195]  J. Price,et al.  Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders , 1998, Molecular Psychiatry.

[196]  H Selye,et al.  A syndrome produced by diverse nocuous agents. 1936. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[197]  T. Dinan,et al.  Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. , 1998, Life sciences.

[198]  D. Charney.  Monoamine dysfunction and the pathophysiology and treatment of depression. , 1998, The Journal of clinical psychiatry.

[199]  A. Zwinderman,et al.  Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression , 1998, Psychological Medicine.

[200]  S. Maier,et al.  Exposure to inescapable but not escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat , 1998, Brain Research.

[201]  G. Kerkhof,et al.  Plasma arginine vasopressin and motor activity in major depression , 1998, Biological Psychiatry.

[202]  F. Bloom,et al.  Subcellular localization of tyrosine hydroxylase (TH) gene transcripts: New insights into the pattern of TH gene expression in the locus coeruleus under pharmacological stimulation , 1998, Biology of the cell.

[203]  P. Sullivan,et al.  Arginine Vasopressin Is Associated with Hypercortisolemia and Suicide Attempts in Depression , 1997, Biological Psychiatry.

[204]  V. Wiegant,et al.  Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression , 1997, Neuropsychopharmacology.

[205]  R. Conley,et al.  Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects , 1997, Psychiatry Research.

[206]  A. Young,et al.  Rapid depletion of plasma tryptophan: a review of studies and experimental methodology , 1997, Journal of psychopharmacology.

[207]  J. Tasker,et al.  Physiological evidence for local excitatory synaptic circuits in the rat hypothalamus. , 1997, Journal of neurophysiology.

[208]  R. Valentino,et al.  Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. , 1997, The Journal of pharmacology and experimental therapeutics.

[209]  H L Miller,et al.  Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. , 1997, Archives of general psychiatry.

[210]  T. Dinan,et al.  Dexamethasone augmentation in treatment‐resistant depression , 1997, Acta psychiatrica Scandinavica.

[211]  J. Tasker,et al.  Physiological Mapping of Local Inhibitory Inputs to the Hypothalamic Paraventricular Nucleus , 1996, The Journal of Neuroscience.

[212]  K. E. Moore,et al.  Dopamine receptor-mediated regulation of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus , 1996, Brain Research.

[213]  G. Asnis,et al.  Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine , 1996, Psychiatry Research.

[214]  R. Binnekade,et al.  Short Stressor Induced Long‐Lasting Increases of Vasopressin Stores in Hypothalamic Corticotropin‐Releasing Hormone (CRH) Neurons in Adult Rats , 1996, Journal of neuroendocrinology.

[215]  E. Moja,et al.  Decrease in plasma phenylalanine and tyrosine after phenylalanine-tyrosine free amino acid solutions in man. , 1996, Life sciences.

[216]  D. Swaab,et al.  Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. , 1996, Archives of general psychiatry.

[217]  N. Barden,et al.  Modulation of Glucocorticoid Receptor Gene Expression by Antidepressant Drugs , 1996, Pharmacopsychiatry.

[218]  A. Dunn,et al.  Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex , 1995, Brain Research Bulletin.

[219]  E. Schmidt,et al.  Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[220]  D F Swaab,et al.  Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. , 1995, The American journal of psychiatry.

[221]  G. Nowak,et al.  Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims , 1995, Brain Research.

[222]  W. Kamphorst,et al.  Increased Cortisol Levels in Aging and Alzheimer's Disease in Postmortem Cerebrospinal Fluid , 1994, Journal of neuroendocrinology.

[223]  D. Swaab,et al.  Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.

[224]  H. Nakane,et al.  CRF receptor antagonist attenuates stress-induced noradrenaline release in the medial prefrontal cortex of rats , 1994, Brain Research.

[225]  D. Swaab,et al.  Similar Age Related Increase of Vasopressin Colocalization in Paraventricular Corticotropin‐Releasing Hormone Neurons in Controls and Alzheimer Patients , 1994, Journal of neuroendocrinology.

[226]  M. Hofman,et al.  Diurnal and Seasonal Rhythms of Neuronal Activity in the Suprachiasmatic Nucleus of Humans , 1993, Journal of biological rhythms.

[227]  G. Chrousos,et al.  Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. , 1993, The Journal of clinical investigation.

[228]  C. Katona,et al.  NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides , 1993, Brain Research.

[229]  R. Ravid,et al.  Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin , 1993, Brain Research.

[230]  D. Jezova,et al.  Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. , 1993, Endocrinology.

[231]  H. Westenberg,et al.  Stimulation of the pituitary-adrenal axis with a low dose [Arg8]-vasopressin in depressed patients and healthy subjects , 1992, European Neuropsychopharmacology.

[232]  M. Palkovits,et al.  Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study , 1992, Brain Research.

[233]  R. Post,et al.  Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. , 1992, The American journal of psychiatry.

[234]  J. Marcusson,et al.  Gamma-aminobutyric acid-B (GABAB) binding sites in postmortem suicide brains. , 1992, Neuropsychobiology.

[235]  M. Hofman,et al.  Seasonal changes in the suprachiasmatic nucleus of man , 1992, Neuroscience Letters.

[236]  A. Kalsbeek,et al.  Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release , 1992, Brain Research.

[237]  H. Akil,et al.  Loss of glucocorticoid fast feedback in depression. , 1991, Archives of general psychiatry.

[238]  M. Caron,et al.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[239]  D. Jezova,et al.  Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. , 1991, Neuroendocrinology.

[240]  T. Phan,et al.  Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment , 1990, Brain Research.

[241]  D. Pickar,et al.  CSF GABA in depressed patients and normal controls , 1989, Biological Psychiatry.

[242]  C. Katona,et al.  Brain GABAB binding sites in depressed suicide victims , 1988, Psychiatry Research.

[243]  A. Dunn.  Stress‐Related Activation of Cerebral Dopaminergic Systems a , 1988, Annals of the New York Academy of Sciences.

[244]  C. Katona,et al.  Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims , 1988, Brain Research.

[245]  Z. Liposits,et al.  Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat , 1987, Histochemistry.

[246]  P. Plotsky.  Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. , 1987, Endocrinology.

[247]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[248]  D. F. Swaab,et al.  The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia , 1985, Brain Research.

[249]  W. Vale,et al.  Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. , 1983, Endocrinology.

[250]  A. Gratton.  Time course analysis of para-chlorophenylalanine induced suppression of self-stimulation behavior , 1982, Pharmacology Biochemistry and Behavior.

[251]  G. Gillies,et al.  Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin , 1982, Nature.

[252]  T. A. Pitler,et al.  Brain aging correlates: retardation by hormonal-pharmacological treatments. , 1981, Science.

[253]  R. Rastogi,et al.  EVIDENCE FOR THE ROLE OF ADRENOCORTICAL HORMONES IN THE REGULATION OF NORADRENALINE AND DOPAMINE METABOLISM IN CERTAIN BRAIN AREAS , 1978, British journal of pharmacology.

[254]  Robert H. Perry,et al.  Neurotransmitter enzyme abnormalities in senile dementia Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue , 1977, Journal of the Neurological Sciences.

[255]  J. Glowinski,et al.  Selective activation of the mesocortical DA system by stress , 1976, Nature.

[256]  H. Selye.  A Syndrome produced by Diverse Nocuous Agents , 1936, Nature.

[257]  J. Price,et al.  Neurocircuitry of Mood Disorders , 2010, Neuropsychopharmacology.

[258]  E. Evers,et al.  Effects of Acute Tryptophan Depletion on Mood and Facial Emotion Perception Related Brain Activation and Performance in Healthy Women with and without a Family History of Depression , 2007, Neuropsychopharmacology.

[259]  J. Cryan,et al.  Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression. , 2005, Trends in pharmacological sciences.

[260]  T. Robbins,et al.  Serotonergic Modulation of Prefrontal Cortex during Negative Feedback in Probabilistic Reversal Learning , 2005, Neuropsychopharmacology.

[261]  S. Feldman,et al.  Hypothalamic mechanisms mediating glutamate effects on the hypothalamo-pituitary-adrenocortical axis , 2005, Journal of Neural Transmission.

[262]  R. Pihl,et al.  Tryptophan depletion causes a rapid lowering of mood in normal males , 2004, Psychopharmacology.

[263]  D. Swaab.  The Human Hypothalamus. Basic and Clinical Aspects : part II: Neuropathology of the human hypothalamus and adjacent brain structures. , 2004 .

[264]  D. Luckenbaugh,et al.  An open-label trial of riluzole in patients with treatment-resistant major depression. , 2004, The American journal of psychiatry.

[265]  R. Derijk,et al.  Anxious–Retarded Depression: Relation with Plasma Vasopressin and Cortisol , 2003, Neuropsychopharmacology.

[266]  H. Akil,et al.  Mineralocorticoid receptor function in major depression. , 2003, Archives of general psychiatry.

[267]  D. Swaab.  The Human Hypothalamus. Basic and Clinical Aspects : part I: Nuclei of the human hypothalamus. , 2003 .

[268]  F. Holsboer,et al.  Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. , 2001, Journal of affective disorders.

[269]  E. Fliers,et al.  Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. , 2000, Progress in brain research.

[270]  I. Heuser,et al.  Cerebrospinal fluid concentrations of corticotropin‐releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment , 1998, Depression and anxiety.

[271]  S. Rivkees.  Basic and Clinical Aspects , 1997 .

[272]  J. Marcusson,et al.  GABA uptake sites in frontal cortex from suicide victims and in aging. , 1997, Neuropsychobiology.

[273]  M. Le Moal,et al.  Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. , 1996, Annual review of pharmacology and toxicology.

[274]  R. Fahlbusch,et al.  In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. , 1994, The Journal of clinical endocrinology and metabolism.

[275]  A. Damasio.  Descartes' error: emotion, reason, and the human brain. avon books , 1994 .

[276]  R. Salomon,et al.  Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. , 1993, Psychopharmacology bulletin.

[277]  R. Salomon,et al.  Acute tryptophan depletion , 1992 .

[278]  G. M. Stocks,et al.  Benzodiazepine binding sites in amygdala and hippocampus of depressed suicide victims. , 1990, Journal of affective disorders.

[279]  Sze Py.  L-Glutamate decarboxylase. , 1979, Advances in experimental medicine and biology.

[280]  S. Gershon,et al.  Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. , 1975, Psychopharmacology communications.